These Analysts Say It’s Not Time to Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Valeant Pharmaceuticals Intl Inc (VRX)
Is Teva Pharmaceutical a Falling Knife to Catch After Plunging over 30%? This week turned out to be a nightmare for shareholders of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after the drug maker missed earnings expectations, lowered its guidance and approved a dividend cut, sending shares tumbling nearly 33%. This is appropriate, in our view, given higher than expected generic drug price erosion and deteriorating economic conditions in Venezuela.
Source:: https://finance.yahoo.com/news/analysts-not-time-buy-teva-180425237.html
